Shanghai, China · Founded 2021 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to focus on the discovery, development, and commercialization of novel targeted radiopharmaceuticals to address significant unmet… Biovision Biomedical Technology is based in Shanghai, China and was founded in 2021. It has raised $42.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$42.3M
Last round
—
Team — not yet on record
No current team members for Biovision Biomedical Technology are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biovision Biomedical Technology with a free account
·Watch Biovision Biomedical Technology: the Monday email on marks, rounds and moves
